This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Aug;11(4):233-4.

doi: 10.1007/s11926-009-0043-z.

The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis

Arthur Kavanaugh¹

Affiliations

PMID: 19691924
DOI: 10.1007/s11926-009-0043-z

Comment

The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis

Arthur Kavanaugh. Curr Rheumatol Rep. 2009 Aug.

. 2009 Aug;11(4):233-4.

doi: 10.1007/s11926-009-0043-z.

Author

Arthur Kavanaugh¹

Affiliation

¹ University of California, San Diego, Division of Rheumatology, Allergy, and Immunology, UCSD Thornton Hospital, USA. akavanaugh@ucsd.edu

PMID: 19691924
DOI: 10.1007/s11926-009-0043-z

No abstract available

PubMed Disclaimer

Comment on

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, Fretzin S, Kunynetz R, Kavanaugh A. Gottlieb A, et al. Lancet. 2009 Feb 21;373(9664):633-40. doi: 10.1016/S0140-6736(09)60140-9. Epub 2009 Feb 11. Lancet. 2009. PMID: 19217154 Clinical Trial.

References

1. N Engl J Med. 2007 Feb 8;356(6):580-92 - PubMed
1. Rheumatology (Oxford). 2003 Jun;42(6):778-83 - PubMed
1. Arthritis Rheum. 2005 Oct;52(10):3279-89 - PubMed
1. Lancet. 2008 May 17;371(9625):1665-74 - PubMed
1. Curr Opin Rheumatol. 2002 Jul;14(4):361-6 - PubMed

Publication types

Actions